Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04698785
Title Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients (REGOMAIN)
Recruitment Recruiting
Gender
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications

osteosarcoma

bone sarcoma

Therapies

Regorafenib

Age Groups: adult | child | senior
Covered Countries FRA


No variant requirements are available.